Detection and quantification of natalizumab
US11680948B2 · kind B2 · utility
0Cited by
34References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2017 |
| Grant date | Jun 20, 2023 |
| Priority date | — |
| Expiry date | Jul 4, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70546
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods and assays for detecting natalizumab in a sample, natalizumab-peptide complexes in a sample, and point-of-care devices for detecting natalizumab in a sample are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.